UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis

Vaccines (Basel), 2017-10, Vol.5 (4), p.34

2017

Volltextzugriff (PDF)

Recent developments of HDAC inhibitors: Emerging indications and novel molecules

British journal of clinical pharmacology, 2021-12, Vol.87 (12), p.4577-4597

2021

Volltextzugriff (PDF)

Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target

Pharmacology & therapeutics (Oxford), 2020-03, Vol.207, p.107464-107464, Article 107464

2020

Volltextzugriff (PDF)

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines

International journal of molecular sciences, 2023-01, Vol.24 (1), p.787

2023

Volltextzugriff (PDF)

The Possibility of an Infectious Etiology of Alzheimer Disease

Molecular neurobiology, 2019-06, Vol.56 (6), p.4479-4491

2019

Volltextzugriff (PDF)

Biological Mechanisms of Atypical and Melancholic Major Depressive Disorder

Current pharmaceutical design, 2021-10, Vol.27 (31), p.3399-3412

2021

Volltextzugriff (PDF)

Advances in the development of new biomarkers for Alzheimer's disease

Translational neurodegeneration, 2022-04, Vol.11 (1), p.25-25, Article 25

2022

Volltextzugriff (PDF)

Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments

British journal of pharmacology, 2021-12, Vol.178 (23), p.4588-4607

2021

Volltextzugriff (PDF)

Extracellular vesicles in cancer nanomedicine

Seminars in cancer biology, 2021-02, Vol.69, p.212-225

2021

Volltextzugriff (PDF)

Sleep Disorders Associated With Alzheimer's Disease: A Perspective

Frontiers in neuroscience, 2018-05, Vol.12, p.330

2018

Volltextzugriff (PDF)

Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules

Frontiers in pharmacology, 2022-11, Vol.13, p.1057083-1057083

2022

Volltextzugriff (PDF)

Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales

Pharmacological research, 2024-11, Vol.209, p.107431, Article 107431

2024

Volltextzugriff (PDF)

The Epigenetics of Migraine

International journal of molecular sciences, 2023-05, Vol.24 (11), p.9127

2023

Volltextzugriff (PDF)

Stem Cells in Clinical Trials on Neurological Disorders: Trends in Stem Cells Origins, Indications, and Status of the Clinical Trials

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11453

2022

Volltextzugriff (PDF)

Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials

Frontiers in pharmacology, 2022-11, Vol.13

2022

Volltextzugriff (PDF)

Alterations of Astrocytes in the Context of Schizophrenic Dementia

Frontiers in pharmacology, 2020-02, Vol.10, p.1612-1612

2020

Volltextzugriff (PDF)

Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers

Seminars in cancer biology, 2022-11, Vol.86 (Pt 2), p.358-375

2022

Volltextzugriff (PDF)

The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo

Drug design, development and therapy, 2018-01, Vol.12, p.1147-1156

2018

Volltextzugriff (PDF)

High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis

Journal of translational medicine, 2021-03, Vol.19 (1), p.133-133, Article 133

2021

Volltextzugriff (PDF)

Advances in development of biomarkers for brain damage and ischemia

Molecular biology reports, 2024-12, Vol.51 (1), p.803, Article 803

2024

Volltextzugriff (PDF)

Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov

Translational psychiatry, 2024-07, Vol.14 (1), p.315-15, Article 315

2024

Volltextzugriff (PDF)

Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics

Pharmacogenomics, 2021-06, Vol.22 (8), p.485-503

2021

Volltextzugriff (PDF)

The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity

European journal of pharmacology, 2020-10, Vol.885, p.173524-173524, Article 173524

2020

Volltextzugriff (PDF)

The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs

Frontiers in pharmacology, 2023-09, Vol.14, p.1228148-1228148

2023

Volltextzugriff (PDF)

Alzheimer's Disease - Future Therapy Based on Dendrimers

Current neuropharmacology, 2019-01, Vol.17 (3), p.288-294

2019

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis

Recent developments of HDAC inhibitors: Emerging indications and novel molecules

Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines

The Possibility of an Infectious Etiology of Alzheimer Disease

Biological Mechanisms of Atypical and Melancholic Major Depressive Disorder

Advances in the development of new biomarkers for Alzheimer's disease

Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments

Extracellular vesicles in cancer nanomedicine

Sleep Disorders Associated With Alzheimer's Disease: A Perspective

Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules

Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales

The Epigenetics of Migraine

Stem Cells in Clinical Trials on Neurological Disorders: Trends in Stem Cells Origins, Indications, and Status of the Clinical Trials

Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials

Alterations of Astrocytes in the Context of Schizophrenic Dementia

Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers

The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo

High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis

Advances in development of biomarkers for brain damage and ischemia

Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov

Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics

The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity

The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs

Alzheimer's Disease - Future Therapy Based on Dendrimers

Suchergebnisse filtern